Literature DB >> 15515784

The level of soluble Granzyme A is elevated in the plasma and in the Vgamma9/Vdelta2 T cell culture supernatants of patients with active Behçet's disease.

A Accardo-Palumbo1, A Ferrante, M Cadelo, F Ciccia, G Parrinello, L Lipari, A R Giardina, M Riili, E Giardina, F Dieli, G Triolo.   

Abstract

OBJECTIVE: Gramzyme A (GrA) is a serine proteinase with trypsin-like activity that is released extracellularly during the degranulation of cytotoxic cells. Among the cytotoxic cells, gamma/delta T cells participate in the early phases of the immune response and are known to express perforin and granzymes constitutively in agreement with their cytolytic pontential.
METHODS: GrA activity was detected using the synthetic substrate N-alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester in the plasma and supernatants of peripheral blood mononuclear cell cultured in the presence of Dimethylallyl pyrophosphate to obtain Vgamma9/Vdelta2 T cell expansion.
RESULTS: Significantly high levels of GrA were found in the serum and supernatants of lymphocytes from patients with active Behçet's disease cultured in the presence of DMAPP. Levels were found to be significantly lower after remission. A positive correlation was observed between GrA levels in the supernatants and the Vgamma9/Vdelta2 T cell expansion factor.
CONCLUSION: These results strongly suggest that Vgamma9/Vdelta2 T cells are active participants in the pathogenesis of the disease through their degranulation and granzyme release.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15515784

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  5 in total

Review 1.  Innate immune cells in the pathogenesis of primary systemic vasculitis.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2015-09-24       Impact factor: 2.631

Review 2.  COVID-19-related oral mucosa lesions among confirmed SARS-CoV-2 patients: a systematic review.

Authors:  Gizem S Erbaş; Aysenur Botsali; Nihan Erden; Canan Arı; Banu Taşkın; Sibel Alper; Secil Vural
Journal:  Int J Dermatol       Date:  2021-09-22       Impact factor: 3.204

3.  Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity.

Authors:  Antonina Accardo-Palumbo; Anna Rita Giardina; Francesco Ciccia; Angelo Ferrante; Alfonso Principato; Rosalia Impastato; Ennio Giardina; Giovanni Triolo
Journal:  Arthritis Res Ther       Date:  2010-06-03       Impact factor: 5.156

Review 4.  Modulation of Inflammation by Extracellular Granzyme A.

Authors:  Kim R van Daalen; Josephine F Reijneveld; Niels Bovenschen
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

5.  Expression of regulatory receptors on γδ T cells and their cytokine production in Behcet's disease.

Authors:  Gunes Parlakgul; Ekin Guney; Burak Erer; Zeki Kılıcaslan; Haner Direskeneli; Ahmet Gul; Guher Saruhan-Direskeneli
Journal:  Arthritis Res Ther       Date:  2013-01-21       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.